The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Caneclear 150 mg hard capsule

Phoenix LabsPA1113/013/001

Main Information

Trade NameCaneclear 150 mg hard capsule
Active SubstancesFluconazole
Dosage FormCapsule, hard
Licence HolderPhoenix Labs
Licence NumberPA1113/013/001

Group Information

ATC CodeJ02AC Triazole derivatives
J02AC01 fluconazole


License statusAuthorised
Licence Issued18/12/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportPDF Version

Generics Information

Interchangeable ListFluconazole 150mg Capsules
Interchangeable List CodeIC0151-062-001
Interchangeable List DocumentPDF of Interchangeable List
« Back